• Login
    View Item 
    •   Home
    • Articles and other publications by RIVM employees
    • Miscellaneous
    • View Item
    •   Home
    • Articles and other publications by RIVM employees
    • Miscellaneous
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    RIVM Publications RepositoryCommunitiesTitleAuthorsIssue DateSubmit Date

    My Account

    LoginRegister

    Statistics

    Display statistics

    Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Average rating
     
       votes
    Cast your vote
    You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.
    Star rating
     
    Your vote was cast
    Thank you for your feedback
    Authors
    Kemmeren, J M
    van Balveren, L
    Kant, A
    de Melker, H
    Type
    Article
    Language
    en
    
    Metadata
    Show full item record
    Title
    Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study.
    Published in
    BMC Public Health 2021; 21(1):1752
    DOI
    10.1186/s12889-021-11767-9
    PMID
    34565374
    URI
    http://hdl.handle.net/10029/625301
    ae974a485f413a2113503eed53cd6c53
    10.1186/s12889-021-11767-9
    Scopus Count
    Collections
    Miscellaneous

    entitlement

    Related articles

    • Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents.
    • Authors: Quiambao BP, Jain H, Bavdekar A, Dubey AP, Kolhe D, Bianco V, Van der Wielen M, Miller JM
    • Issue date: 2016 Aug 2
    • Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    • Authors: van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM
    • Issue date: 2017 Aug 24
    • Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial.
    • Authors: Borja-Tabora CF, Montalban C, Memish ZA, Boutriau D, Kolhe D, Miller JM, Van der Wielen M
    • Issue date: 2015 Oct 6
    • Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines.
    • Authors: Vesikari T, Forsten A, Bianco V, Van der Wielen M, Miller JM
    • Issue date: 2015 Dec
    • Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers.
    • Authors: Bona G, Castiglia P, Zoppi G, de Martino M, Tasciotti A, D'Agostino D, Han L, Smolenov I
    • Issue date: 2016 Jun 17

    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.